Login / Signup

Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial.

Di WuJing LiDong XuJoan T MerrillRonald F Van VollenhovenYi LiuJiankang HuYang LiFen LiChenghui HuangGuochun WangXiao-Mei LiJianhong ZhaoDongbao ZhaoCibo HuangHuaxiang LiuWei WeiGuixiu ShiFuai LuXiaoxia ZuoLiqi BiZhijun LiXiaoxia WangMiaojia ZhangNing TieJuan LiHanyou MoJianmin FangChunde BaoFengchun Zhang
Published in: Annals of the rheumatic diseases (2024)
ClinicalTrials.gov Registry (NCT02885610).
Keyphrases
  • double blind
  • systemic lupus erythematosus
  • placebo controlled
  • clinical trial
  • disease activity
  • phase iii
  • study protocol
  • phase ii
  • rheumatoid arthritis
  • randomized controlled trial
  • open label